CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 90 enrolled
Drug / intervention
Levobupivacaine Hydrochloridedrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03258697
NCT03258697N/ACompleted

The Pharmacokinetics and Effectiveness of Different Methods of Local LevoBupivacaine Injection, a Prospective Randomized Case Control Clinical Study on Primary Total Joint Replacement Model.

Chang Gung Memorial Hospital·interventional·Posted Aug 23, 2017·Updated Jun 4, 2024

In Brief

A clinical study evaluating Levobupivacaine Hydrochloride for Arthropathy. Completed, enrolled 90 participants across 1 site.

Detailed Summary

Total joint replacement is an ideal procedure to treat end stage joint disease. Good post-op pain relief could accelerate patient recovery and rehabilitation, and decrease admission days and medical cost. Local injection of LevoBupivacaine is an effective method in post-operative pain control. The effectiveness of local analgesia was noticed clinically. However, thorough studies about the pharmacokinetics of LevoBupivacaine, maintenance of effect, influence of post-operative rehabilitation are not well studied in different way of injection. The purpose of this study is to evaluate and analyze the pharmacokinetics and effect of local Levobupivacaine injection in different ways, the amount of post-operative fentanyl requirement after local injection, time to first fentanyl request, pain score, immediate post-operative function, side effect of analgesic agents, and medical cost, and to improve the quality of total joint replacement post-operative care.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArthropathy
CountriesTaiwan
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedAug 23, 2017
Enrollment StartOct 17, 2017
Primary CompletionJan 31, 2019
Study CompletionMay 31, 2019
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 8.9 years ago

Interventions

Levobupivacaine Hydrochloridedrug

Different way of LevoBupivacaine injection